Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 8, 2011, Pages

  Wang, Jia Ning ^a,b   Shi, Ning ^a   Xie, Wei Bing ^a   Guo, Xia ^a   Chen, Shi You ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

migration; proliferation; response gene to complement 32; restenosis; vascular smooth muscle cells

Indexed keywords

ADENOVIRUS VECTOR; GUANOSINE TRIPHOSPHATASE; RHO KINASE; RHO KINASE 2ALPHA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAROTID ARTERY INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FOCAL ADHESION; GENE; GENE OVEREXPRESSION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; MALE; MORPHOMETRICS; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; RGC 32 GENE; SMOOTH MUSCLE FIBER; STRESS FIBER; VASCULAR LESION;

ANIMALS; BASE SEQUENCE; CAROTID ARTERY INJURIES; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; MALE; MUSCLE PROTEINS; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NERVE TISSUE PROTEINS; RAS PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING;

EID: 80051548543     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.230706     Document Type: Review

References (34)

1. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263.
2. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 2010;56:S1-S42.
3. Lopez JJ, Keyes MJ, Nathan S, Piana R, Pencina M, Dhar G, Marso S, Rao S, Shammo S, Marquardt W, Cohen DJ, Kleiman NS. Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J. 2010;160:767-774.
4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
5. Chatterjee S, Pandey A. Drug eluting stents: friend or foe? A review of cellular mechanisms behind the effects of paclitaxel and sirolimus eluting stents. Curr Drug Metab. 2008;9:554-566. (Pubitemid 352025187)
6. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 2003;23:1510-1520. (Pubitemid 37108191)
7. Yaghini FA, Song CY, Lavrentyev EN, Ghafoor HU, Fang XR, Estes AM, Campbell WB, Malik KU. Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation. Hypertension. 2010;55: 1461-1467.
8. Zhang C, Zhao YX, Zhang YH, Zhu L, Deng BP, Zhou ZL, Li SY, Lu XT, Song LL, Lei XM, Tang WB, Wang N, Pan CM, Song HD, Liu CX, Dong B, Zhang Y, Cao Y. Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc Natl Acad Sci USA. 2010;107:15886-15891.
9. Zhang F, Hu Y, Xu Q, Ye S. Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS One. 2010;5:e12323.
10. Ikeda Y, Imai Y, Kumagai H, Nosaka T, Morikawa Y, Hisaoka T, Manabe I, Maemura K, Nakaoka T, Imamura T, Miyazono K, Komuro I, Nagai R, Kitamura T. Vasorin, a transforming growth factorα-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Proc Natl Acad Sci USA. 2004;101: 10732-10737. (Pubitemid 38955811)
11. Fu M, Zhang J, Tseng YH, Cui T, Zhu X, Xiao Y, Mou Y, De Leon H, Chang MM, Hamamori Y, Kahn CR, Chen YE. Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration. Circulation. 2005;111:1071-1077. (Pubitemid 40354527)
12. Badea T, Niculescu F, Soane L, Fosbrink M, Sorana H, Rus V, Shin ML, Rus H. RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J Biol Chem. 2002;277:502-508. (Pubitemid 34952085)
13. Badea TC, Niculescu FI, Soane L, Shin ML, Rus H. Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J Biol Chem. 1998;273:26977-26981. (Pubitemid 28471720)
14. Li F, Luo Z, Huang W, Lu Q, Wilcox CS, Jose PA, Chen S. Response gene to complement 32, a novel regulator for transforming growth factor-γ-induced smooth muscle differentiation of neural crest cells. J Biol Chem. 2007;282:10133-10137. (Pubitemid 47093391)
15. An X, Jin Y, Guo H, Foo SY, Cully BL, Wu J, Zeng H, Rosenzweig A, Li J. Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor. Circulation. 2009;120:617-627.
16. Fosbrink M, Cudrici C, Tegla CA, Soloviova K, Ito T, Vlaicu S, Rus V, Niculescu F, Rus H. Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp Mol Pathol. 2009;86:87-94.
17. Brown MR, Miller FJ Jr, Li WG, Ellingson AN, Mozena JD, Chatterjee P, Engelhardt JF, Zwacka RM, Oberley LW, Fang X, Spector AA, Weintraub NL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res. 1999; 85:524-533. (Pubitemid 29431953)
18. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007;2:1236-1247. (Pubitemid 46908240)
19. Shen C, Buck AK, Liu X, Winkler M, Reske SN. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 2003;539:111-114. (Pubitemid 36351297)
20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998;95:2509-2514. (Pubitemid 28145972)
21. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215. (Pubitemid 13039947)
22. Tulis DA. Rat carotid artery balloon injury model. Methods Mol Med. 2007;139:1-30.
23. Dollery CM, Humphries SE, McClelland A, Latchman DS, McEwan JR. In vivo adenoviral gene transfer of TIMP-1 after vascular injury reduces neointimal formation. Ann N Y Acad Sci. 1999;878:742-743. (Pubitemid 29353663)
24. Tulis DA. Histological and morphometric analyses for rat carotid balloon injury model. Methods Mol Med. 2007;139:31-66.
25. Huang WY, Li ZG, Rus H, Wang X, Jose PA, Chen SY. RGC-32 mediates transforming growth factor-γ-induced epithelial-mesenchymal transition in human renal proximal tubular cells. J Biol Chem. 2009;284: 9426-9432.
26. Guo X, Jose PA, Chen SY. Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells. Am J Physiol Cell Physiol. 2011;300:C1415-C1421.
27. Chen SY, Crawford M, Day RM, Briones VR, Leader JE, Jose PA, Lechleider RJ. RhoA modulates Smad signaling during transforming growth factor-γ-induced smooth muscle differentiation. J Biol Chem. 2006;281:1765-1770.
28. Chen SY, Lechleider RJ. Transforming growth factor-γ-induced differentiation of smooth muscle from a neural crest stem cell line. Circ Res. 2004;94:1195-1202. (Pubitemid 38656406)
29. Choi KH, Kim JE, Song NR, Son JE, Hwang MK, Byun S, Kim JH, Lee KW, Lee HJ. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res. 2010;85:836-844.
30. Yang D, Tan Z, Pan JY, Wang TH. 17-Estradiol inhibits vascular smooth muscle cell proliferation and c-fos expression: role of nitric oxide. Sheng Li Xue Bao. 2002;54:17-22.
31. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996;392: 189-193. (Pubitemid 26276745)
32. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801. (Pubitemid 38823766)
33. Reynet C, Kahn CR. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science. 1993;262:1441-1444. (Pubitemid 24035065)
34. Tanaka T, Takada H, Nomura A, Ohga S, Shibata R, Hara T. Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin Exp Immunol. 2005;140:524-531. (Pubitemid 40813964)